IL160755A0 - Urea compounds active as vanilloid receptor antagonists for the treatment of pain - Google Patents
Urea compounds active as vanilloid receptor antagonists for the treatment of painInfo
- Publication number
- IL160755A0 IL160755A0 IL16075502A IL16075502A IL160755A0 IL 160755 A0 IL160755 A0 IL 160755A0 IL 16075502 A IL16075502 A IL 16075502A IL 16075502 A IL16075502 A IL 16075502A IL 160755 A0 IL160755 A0 IL 160755A0
- Authority
- IL
- Israel
- Prior art keywords
- pain
- treatment
- receptor antagonists
- urea compounds
- vanilloid receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0122156A GB0122156D0 (en) | 2001-09-13 | 2001-09-13 | Novel compounds |
GB0130503A GB0130503D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
GB0130505A GB0130505D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
GB0130547A GB0130547D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
PCT/GB2002/004206 WO2003022809A2 (fr) | 2001-09-13 | 2002-09-13 | Nouveaux composes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160755A0 true IL160755A0 (en) | 2004-08-31 |
Family
ID=27447989
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16075502A IL160755A0 (en) | 2001-09-13 | 2002-09-13 | Urea compounds active as vanilloid receptor antagonists for the treatment of pain |
IL160755A IL160755A (en) | 2001-09-13 | 2004-03-04 | N - (2 - bromophenyl) - n' [((r) - 1 - (5 - trifluoromethyl - 2 - pyridyl) pyrrolidin - 3 - yl)] urea, pharmaceutical compositions comprising it and process for its preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL160755A IL160755A (en) | 2001-09-13 | 2004-03-04 | N - (2 - bromophenyl) - n' [((r) - 1 - (5 - trifluoromethyl - 2 - pyridyl) pyrrolidin - 3 - yl)] urea, pharmaceutical compositions comprising it and process for its preparation |
Country Status (32)
Country | Link |
---|---|
US (1) | US8063078B2 (fr) |
EP (3) | EP2036902A3 (fr) |
JP (2) | JP4463552B2 (fr) |
KR (3) | KR100955967B1 (fr) |
CN (1) | CN1247568C (fr) |
AP (1) | AP1818A (fr) |
AR (1) | AR038786A1 (fr) |
AT (1) | ATE420083T1 (fr) |
AU (1) | AU2002329397B2 (fr) |
BR (1) | BR0212468A (fr) |
CA (1) | CA2458632C (fr) |
CY (1) | CY1109449T1 (fr) |
DE (1) | DE60230773D1 (fr) |
DK (1) | DK1425277T3 (fr) |
EA (1) | EA007731B1 (fr) |
ES (1) | ES2316607T3 (fr) |
HK (1) | HK1066534A1 (fr) |
HU (1) | HUP0401923A3 (fr) |
IL (2) | IL160755A0 (fr) |
MA (1) | MA26216A1 (fr) |
MX (1) | MXPA04002379A (fr) |
MY (1) | MY138086A (fr) |
NO (3) | NO327009B1 (fr) |
NZ (1) | NZ531137A (fr) |
OA (1) | OA12659A (fr) |
PE (1) | PE20030417A1 (fr) |
PL (1) | PL213639B1 (fr) |
PT (1) | PT1425277E (fr) |
SI (1) | SI1425277T1 (fr) |
TW (1) | TWI283665B (fr) |
UY (1) | UY27446A1 (fr) |
WO (1) | WO2003022809A2 (fr) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI283665B (en) | 2001-09-13 | 2007-07-11 | Smithkline Beecham Plc | Novel urea compound, pharmaceutical composition containing the same and its use |
PT1472225E (pt) | 2002-02-01 | 2010-07-30 | Euro Celtique Sa | 2-piperazina-piridinas uteis para tratar a dor |
US7074805B2 (en) | 2002-02-20 | 2006-07-11 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
CA2476936A1 (fr) * | 2002-02-20 | 2003-08-28 | Chih-Hung Lee | Composes azabicycliques fusionnes qui inhibent le recepteur (vr1) sous-type 1 du recepteur vanilloide |
US6974818B2 (en) | 2002-03-01 | 2005-12-13 | Euro-Celtique S.A. | 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain |
WO2004002983A2 (fr) | 2002-06-28 | 2004-01-08 | Euro-Celtique, S.A. | Agents therapeutiques utiles pour le traitement de la douleur |
US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
GB0221157D0 (en) * | 2002-09-12 | 2002-10-23 | Glaxo Group Ltd | Novel treatment |
WO2004024710A1 (fr) * | 2002-09-13 | 2004-03-25 | Glaxo Group Limited | Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs |
US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7381840B2 (en) | 2002-12-06 | 2008-06-03 | Xention Limited | Tetrahydro-naphthalene derivatives |
GB0229808D0 (en) * | 2002-12-20 | 2003-01-29 | Glaxo Group Ltd | Novel compositions |
US6933311B2 (en) * | 2003-02-11 | 2005-08-23 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
JP2006519826A (ja) | 2003-03-06 | 2006-08-31 | グラクソ グループ リミテッド | 疼痛治療のための複素環式尿素誘導体 |
EP1601665A2 (fr) * | 2003-03-07 | 2005-12-07 | Glaxo Group Limited | Derives d'uree |
GB0305426D0 (en) * | 2003-03-08 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
SE0301446D0 (sv) | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | New Compounds |
WO2004103954A1 (fr) | 2003-05-20 | 2004-12-02 | Ajinomoto Co., Inc. | Derive d'amide |
EP1493438A1 (fr) * | 2003-07-03 | 2005-01-05 | Bayer HealthCare AG | Inhibiteurs du recepteur vanilloide (VR1) dans le traitement de la douleur associée au VIH |
GB0319150D0 (en) | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
DE602004019294D1 (de) * | 2003-10-01 | 2009-03-19 | Xention Ltd | Tetrahydronaphthalin- und harnstoffderivate |
WO2005035471A1 (fr) | 2003-10-14 | 2005-04-21 | Ajinomoto Co., Inc. | Derive ethere |
CA2542494A1 (fr) * | 2003-10-15 | 2005-05-06 | Bayer Healthcare Ag | Derives de tetrahydro-naphthalene et d'uree |
US7683076B2 (en) | 2003-11-08 | 2010-03-23 | Bayer Schering Pharma Aktiengesellschaft | Tetrahydro-quinolinylurea derivatives |
EP1736465A4 (fr) * | 2004-03-31 | 2009-06-17 | Ajinomoto Kk | Dérivés d'aniline |
WO2006002361A2 (fr) | 2004-06-24 | 2006-01-05 | Incyte Corporation | 2-methylpropanamides et leur utilisation comme produits pharmaceutiques |
US7879866B2 (en) | 2004-07-19 | 2011-02-01 | Dorte Xenia Gram | Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders |
KR20060087386A (ko) | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
WO2006098554A1 (fr) * | 2005-03-16 | 2006-09-21 | Amorepacific Corporation | Nouveaux composes, isomere de ceux-ci ou sels pharmaceutiquement acceptables de ceux-ci en tant qu’antagonistes du recepteur vanilloide ; et composition pharmaceutique contenant ceux-ci |
WO2007046867A2 (fr) * | 2005-05-19 | 2007-04-26 | Xenon Pharmaceuticals Inc. | Derives de piperidine et leurs utilisations comme agents therapeutiques |
UY30048A1 (es) | 2005-12-23 | 2007-07-31 | Astrazeneca Ab | Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones |
EP1889830A1 (fr) * | 2006-07-10 | 2008-02-20 | Pharmeste S.r.l. | Amides biarylcarboxyaryles en tant que modulateurs du recepteur vanilloid-1. |
EP2054411B1 (fr) * | 2006-07-27 | 2014-08-20 | Amorepacific Corporation | Nouveaux composés, isomères de ceux-ci, ou sels acceptables sur le plan pharmaceutique de ceux-ci utilisés en tant qu'antagonistes du récepteur vanilloïde, et compositions pharmaceutiques les contenant |
EP1882687A1 (fr) * | 2006-07-27 | 2008-01-30 | Amorepacific Corporation | Composés hétérocycliques, leur utilisation comme antagonistes du récepteur vanilloide et les compositions pharmaceutiques qui les contiennent |
TWI433839B (zh) | 2006-08-11 | 2014-04-11 | Neomed Inst | 新穎的苯并咪唑衍生物290 |
EP2054390B1 (fr) | 2006-08-25 | 2012-04-11 | Abbott Laboratories | Dérivés d'indazole inhibant trpv1, et leur utilisation |
JP2010513557A (ja) | 2006-12-20 | 2010-04-30 | アボット・ラボラトリーズ | 疼痛治療のためのtrpv1バニロイド受容体アンタゴニストとしてのn−(5,6,7,8−テトラヒドロナフタレン−1−イル)尿素誘導体および関連化合物 |
EP2489660A1 (fr) | 2008-03-20 | 2012-08-22 | Abbott Laboratories | Procédés de fabrication d'agents de système nerveux central qui sont des antagonistes TRPV1 |
EP2264031B1 (fr) | 2008-04-18 | 2015-04-15 | Daewoong Pharmaceutical Co., Ltd. | Nouveau dérivé de benzoxazine benzimidazole, composition pharmaceutique le comprenant et application s'y rapportant |
JP4746713B2 (ja) * | 2008-05-07 | 2011-08-10 | 大日本住友製薬株式会社 | 環状アミン−1−カルボン酸エステル誘導体およびそれを含有する医薬組成物 |
WO2010026128A1 (fr) * | 2008-09-02 | 2010-03-11 | Glaxo Group Limited | N-(3-méthyl-5-isoquinolinyl)-n'-((3r)-l-[5-(trifluorométhyl)-2-pyridinyl]-3-pyrrolidinyl) urée pour le traitement de la rhinite |
JP2012501315A (ja) * | 2008-09-02 | 2012-01-19 | グラクソ グループ リミテッド | 鼻炎を治療するためのtrpvlアンタゴニストsb−705498 |
JP2013028536A (ja) * | 2009-11-11 | 2013-02-07 | Dainippon Sumitomo Pharma Co Ltd | 環状アミン−1−カルボン酸エステル誘導体およびそれを含有する医薬組成物 |
WO2012045729A1 (fr) | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Dérivés d'imidazo[1,2-a]pyridine et de pyrazolo[1,5-a]pyridine en tant qu'antagonistes du trpv1 |
KR101293384B1 (ko) | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 |
WO2012072512A1 (fr) | 2010-11-29 | 2012-06-07 | Glaxo Group Limited | Carboxamides de n-cyclo-butylimidazopyridine ou de n-cyclo-pyrazolopyridine comme antagonistes de trpv1 |
GB201101517D0 (en) * | 2011-01-28 | 2011-03-16 | Proximagen Ltd | Receptor antagonists |
EP2697221A1 (fr) | 2011-04-11 | 2014-02-19 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine-méthylamine à titre d'antagoniste des trpv1 |
DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3424761A (en) * | 1966-03-07 | 1969-01-28 | Robins Co Inc A H | 3-ureidopyrrolidines |
US3424760A (en) * | 1966-03-07 | 1969-01-28 | Robins Co Inc A H | 3-ureidopyrrolidines |
GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
DE68918991T2 (de) | 1988-06-17 | 1995-04-27 | Procter & Gamble | Anwendung von Vanillin-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Herpes simplex-Infektion. |
HU206082B (en) | 1988-12-23 | 1992-08-28 | Sandoz Ag | Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds |
CA2017383A1 (fr) | 1989-06-08 | 1990-12-08 | Raymond R. Martodam | Utilisation de vanilloides pour le traitement des affections ou des troubles respiratoires |
WO1992009285A1 (fr) | 1990-11-27 | 1992-06-11 | The Procter & Gamble Company | Combinaisons de composes vanilloides et de composes phosphonates antiviraux pour le traitement d'infections par herpes |
US5149704A (en) | 1991-05-03 | 1992-09-22 | Abbott Laboratories | Platelet activating antagonists |
CA2197364A1 (fr) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Compose phenolique et methode de preparation |
AU8270298A (en) * | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
CA2294042A1 (fr) * | 1997-06-26 | 1999-01-07 | David Kent Herron | Agents antithrombotiques |
JP2000080085A (ja) | 1997-09-01 | 2000-03-21 | Kyorin Pharmaceut Co Ltd | 6,7−非対称ジ置換キノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法 |
CN1210254C (zh) | 1999-02-22 | 2005-07-13 | 株式会社太平洋 | 作为有效的香草类受体激动剂和镇痛药的含有树脂毒素药效基团的香草类类似物,其组合物以及应用 |
ATE278674T1 (de) | 1999-03-12 | 2004-10-15 | Boehringer Ingelheim Pharma | Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel |
EP1220836A2 (fr) * | 1999-10-15 | 2002-07-10 | Bristol-Myers Squibb Pharma Company | Amines benzyle cycloalkyle comme modulateurs de l'activite du recepteur de la chimiokine |
NZ523526A (en) | 2000-07-20 | 2004-10-29 | Neurogen Corp | Diaryl piperazines as capsaicin receptor ligands |
EP1311477A4 (fr) | 2000-08-21 | 2005-01-12 | Pacific Corp | Nouveaux derives d'acide thiocarbamique et compositions pharmaceutiques contenant lesdits derives |
CN100439332C (zh) | 2000-08-21 | 2008-12-03 | 株式会社太平洋 | 硫脲衍生物以及包含该衍生物的药物组合物 |
ATE328868T1 (de) | 2000-08-21 | 2006-06-15 | Pacific Corp | Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten |
JP2002080073A (ja) | 2000-09-07 | 2002-03-19 | Kyokuto Kobunshi Kk | 電子レンジ用自動開孔袋 |
JP2002088073A (ja) * | 2000-09-08 | 2002-03-27 | Yamanouchi Pharmaceut Co Ltd | 抗アンドロゲン剤 |
GB0110901D0 (en) | 2001-05-02 | 2001-06-27 | Smithkline Beecham Plc | Novel Compounds |
TWI283665B (en) * | 2001-09-13 | 2007-07-11 | Smithkline Beecham Plc | Novel urea compound, pharmaceutical composition containing the same and its use |
CN1678586A (zh) * | 2002-06-27 | 2005-10-05 | 舍林股份公司 | 取代的喹啉ccr5受体拮抗剂 |
WO2004024710A1 (fr) * | 2002-09-13 | 2004-03-25 | Glaxo Group Limited | Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs |
GB0229808D0 (en) | 2002-12-20 | 2003-01-29 | Glaxo Group Ltd | Novel compositions |
CA2563494A1 (fr) | 2004-04-20 | 2005-11-03 | Bayer Healthcare Ag | Derives d'uree utilises en tant qu'antagonistes du recepteur vanilloide (vr1) |
-
2002
- 2002-09-11 TW TW091120671A patent/TWI283665B/zh not_active IP Right Cessation
- 2002-09-11 PE PE2002000895A patent/PE20030417A1/es not_active Application Discontinuation
- 2002-09-11 MY MYPI20023391A patent/MY138086A/en unknown
- 2002-09-12 UY UY27446A patent/UY27446A1/es not_active Application Discontinuation
- 2002-09-12 AR ARP020103454A patent/AR038786A1/es active IP Right Grant
- 2002-09-13 DK DK02765023T patent/DK1425277T3/da active
- 2002-09-13 BR BR0212468-8A patent/BR0212468A/pt not_active IP Right Cessation
- 2002-09-13 AU AU2002329397A patent/AU2002329397B2/en not_active Ceased
- 2002-09-13 DE DE60230773T patent/DE60230773D1/de not_active Expired - Lifetime
- 2002-09-13 OA OA1200400070A patent/OA12659A/en unknown
- 2002-09-13 EA EA200400432A patent/EA007731B1/ru not_active IP Right Cessation
- 2002-09-13 HU HU0401923A patent/HUP0401923A3/hu unknown
- 2002-09-13 KR KR1020097003812A patent/KR100955967B1/ko not_active IP Right Cessation
- 2002-09-13 KR KR1020047003680A patent/KR101063679B1/ko not_active IP Right Cessation
- 2002-09-13 EP EP08172882A patent/EP2036902A3/fr not_active Withdrawn
- 2002-09-13 CN CNB028177177A patent/CN1247568C/zh not_active Expired - Fee Related
- 2002-09-13 JP JP2003526885A patent/JP4463552B2/ja not_active Expired - Fee Related
- 2002-09-13 KR KR1020107014626A patent/KR20100082390A/ko not_active Application Discontinuation
- 2002-09-13 PT PT02765023T patent/PT1425277E/pt unknown
- 2002-09-13 NZ NZ531137A patent/NZ531137A/en not_active IP Right Cessation
- 2002-09-13 CA CA2458632A patent/CA2458632C/fr not_active Expired - Fee Related
- 2002-09-13 AT AT02765023T patent/ATE420083T1/de active
- 2002-09-13 SI SI200230792T patent/SI1425277T1/sl unknown
- 2002-09-13 WO PCT/GB2002/004206 patent/WO2003022809A2/fr active Application Filing
- 2002-09-13 PL PL369026A patent/PL213639B1/pl not_active IP Right Cessation
- 2002-09-13 EP EP10179466A patent/EP2298757A3/fr not_active Withdrawn
- 2002-09-13 EP EP02765023A patent/EP1425277B8/fr not_active Expired - Lifetime
- 2002-09-13 AP APAP/P/2004/002982A patent/AP1818A/en active
- 2002-09-13 MX MXPA04002379A patent/MXPA04002379A/es active IP Right Grant
- 2002-09-13 ES ES02765023T patent/ES2316607T3/es not_active Expired - Lifetime
- 2002-09-13 IL IL16075502A patent/IL160755A0/xx unknown
- 2002-09-13 US US10/489,277 patent/US8063078B2/en not_active Expired - Fee Related
-
2004
- 2004-03-04 IL IL160755A patent/IL160755A/en not_active IP Right Cessation
- 2004-03-10 NO NO20041003A patent/NO327009B1/no not_active IP Right Cessation
- 2004-03-12 MA MA27573A patent/MA26216A1/fr unknown
- 2004-11-30 HK HK04109442.1A patent/HK1066534A1/xx unknown
-
2008
- 2008-12-04 NO NO20085077A patent/NO20085077L/no not_active Application Discontinuation
- 2008-12-04 NO NO20085078A patent/NO20085078L/no unknown
-
2009
- 2009-03-19 CY CY20091100306T patent/CY1109449T1/el unknown
- 2009-12-08 JP JP2009278584A patent/JP2010100632A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160755A0 (en) | Urea compounds active as vanilloid receptor antagonists for the treatment of pain | |
AU2003270199A1 (en) | Urea compounds active as vanilloid receptor antagonists for the treatment of pain | |
NO20034122L (no) | Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte | |
HK1047580B (zh) | 在糖尿病治療中作為糖皮質激素受體對抗劑的二苯並吡喃 | |
WO2002072536A8 (fr) | Derives d'uree ayant une activite antagoniste du recepteur vanilloide (vr1) | |
IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
NO20020574D0 (no) | Substituerte 1,5-dihydropyrrol-2-onderivater som er virksomme som NMDA-reseptorantagonister for behandlingen av smertetilstanden | |
HUP0202253A3 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
AU2003290059A8 (en) | Use of cd137 antagonists for the treatment of tumors | |
IL157145A0 (en) | Use of dc23 antagonists for the treatment of neoplastic disorders | |
IL158829A0 (en) | Exothermic formulations for the treatment of ectoparasites | |
HUP0303236A3 (en) | Carbamate compounds for use in the treatment of pain | |
EP1399175A4 (fr) | Usages therapeutiques d'antagonistes de rank | |
AU2003264297A1 (en) | Use of vanilloid receptor antagonists for the treatment of pain | |
EP1208101A4 (fr) | Antagonistes du recepteur de la vitronectine utiles pour le traitement des accidents vasculaires cerebraux | |
AU2002315522A1 (en) | Receptor agonists useful for the treatment of pain | |
HUP0300313A3 (en) | Compound, pharmaceutical composition containing it and its use for the treatment of pain | |
EP1451308A4 (fr) | Utilisation therapeutique de composes aziridino | |
AU2003245995A8 (en) | Use of gaba-c receptor antagonists for the treatment of myopia | |
AU2002324407A1 (en) | N-type calcium channel antagonists for the treatment of pain | |
AU2002326276A1 (en) | N-type calcium channel antagonists for the treatment of pain | |
AU2002364456A8 (en) | Use of compounds of the benzamide family as immunosuppressant | |
SI1200402T1 (sl) | Substituirani 1,5-dihidropirol-2-on-derivati, ucinkoviti kot antagonisti NMDA-receptorja za tretiranje bolecinskih stanj | |
AU2002327697A1 (en) | Compounds for the treatment of pain | |
GB9918000D0 (en) | Compositions for the treatment of pain |